Immediate Impact

58 standout
Sub-graph 1 of 23

Citing Papers

Global burden of MAFLD, MAFLD related cirrhosis and MASH related liver cancer from 1990 to 2021
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
5 intermediate papers

Works of John Ritter being referenced

Effect of Steatohepatitis Associated with Irinotecan or Oxaliplatin Pretreatment on Resectability of Hepatic Colorectal Metastases
2005

Author Peers

Author Last Decade Papers Cites
John Ritter 382 152 104 289 174 5 492
M. Di Maso 235 189 189 293 194 10 560
N. Santana 279 143 182 70 83 8 519
Rabih Nemr 171 277 97 341 135 4 431
G. Plant 344 289 117 429 53 13 565
Shaihong Zhu 160 266 168 122 110 10 526
Joseph Fortner 310 215 72 92 156 7 427
Alessio Bridda 90 195 180 329 211 12 562
J.F. Ouellet 110 354 44 134 71 5 543
A. String 109 225 121 225 106 9 435
Antonin Kayser 170 25 105 154 234 7 443

All Works

Loading papers...

Rankless by CCL
2026